The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 346, Issue 3, 2006, Pages 919-925

  Perez Vizcaino, Francisco ^a,b   Bishop Bailley, David ^a   Lodi, Federica ^b   Duarte, Juan ^c   Cogolludo, Angel ^b   Moreno, Laura ^b   Bosca, Lisardo ^d   Mitchell, Jane A ^e   Warner, Timothy D ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b SCHOOL OF MEDICINE   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Flavonoid; Intimal; JNK; Quercetin; Vascular smooth muscle

Indexed keywords

FLAVONOID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; QUERCETIN; ROSIGLITAZONE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; AORTA INTIMA; AORTA MEDIA; APOPTOSIS; ARTICLE; BALLOON; CAROTID ARTERY; CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FRAGMENTATION REACTION; MALE; NEWBORN; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CELL NUCLEUS; CELL SHAPE; CELLS, CULTURED; ENZYME ACTIVATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIGANDS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PHOSPHORYLATION; PPAR GAMMA; QUERCETIN; RATS; REACTIVE OXYGEN SPECIES; TUNICA INTIMA;

EID: 33746929943     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.198     Document Type: Article

References (33)

1. Intengan H.D., and Schiffrin E.L. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hipertensión 38 (2001) 581-587
2. Frid M.G., Moiseeva E.P., and Stenmark K.R. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ. Res. 75 (1994) 669-681
3. Shanahan C.M., and Weissberg P.L. Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 333-338
4. Majesky M.W., Giachelli C.M., Reidy M.A., and Schwartz S.M. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ. Res. 71 (1992) 759-768
5. Bishop-Bailey D., Hla T., and Warner T.D. Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy. Circ. Res. 91 (2002) 210-217
6. Lau H.K.F. Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes. Cardiovasc. Res. 43 (1999) 1049-1059
7. Hertog M.G., Feskens E.J., Hollman P.C., Katan N.B., and Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 342 (1993) 1007-1011
8. Huxley R.R., and Neil H.A. The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 57 (2003) 904-908
9. Duarte J., Perez Vizcaino F., Utrilla P., Jimenez J., Tamargo J., and Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen. Pharmacol. 24 (1993) 857-862
10. Duarte J., Perez-Palencia R., Vargas F., Ocete M.A., Perez-Vizcaino F., Zarzuelo A., and Tamargo J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol. 133 (2001) 117-124
11. Yoshizumi M., Tsuchiya K., Kirima K., Kyaw M., Suzaki Y., and Tamaki T. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol. Pharmacol. (2001) 656-665
12. Yoshizumi M., Tsuchiya K., Suzaki Y., Kirima K., Kyaw M., Moon J.H., Terao J., and Tamaki T. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem. Biophys. Res. Commun. 293 (2002) 1458-1465
13. Alcocer F., Whitley D., Salazar-Gonzalez J.F., Jordan W.D., Sellers M.T., Eckhoff D.E., Suzuki K., Macrae C., and Bland K.I. Quercetin inhibits human vascular smooth muscle cell proliferation and migration. Surgery 131 (2002) 198-204
14. Moon S.K., Cho G.O., Jung S.Y., Gal G.W., Kwon T.K., Lee Y.C., Madamanchi N.R., and Kim C.H. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 301 (2003) 1069-1078
15. Kim S., and Iwao H. Stress and vascular responses: mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling. J. Pharmacol. Sci. 91 (2003) 177-181
16. Lau H.K.F. Cytotoxicity of nitric oxide donors in smooth muscle cells is dependent on phenotype, and mainly due to apoptosis. Atherosclerosis 166 (2003) 223-232
17. + channels and pulmonary vasoconstriction: role of protein kinase Czeta. Circ. Res. 93 (2003) 656-663
18. Shih C.M., Lin H., Liang Y.C., Lee W.S., Bi W.F., and Juan S.H. Concentration-dependent differential effects of quercetin on rat aortic smooth muscle cells. Eur. J. Pharmacol. 496 (2004) 41-48
19. Wyllie A.H. Cell death: a new classification separating apoptosis from necrosis. In: Bowen I.D., and Lockshin R.A. (Eds). Cell Death in Biology and Pathology (1991), Chapman & Hall, London and New York 9-34
20. Kuo P.C., Liu H.F., and Chao J.I. Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J. Biol. Chem. 279 (2004) 55875-55885
21. Iwao K., and Tsukamoto I. Quercetin inhibited DNA synthesis and induced apoptosis associated with increase in c-fos mRNA level and the upregulation of p21WAF1CIP1 mRNA and protein expression during liver regeneration after partial hepatectomy. Biochim. Biophys. Acta 1427 (1999) 112-120
22. Plaumann B., Fritsche M., Rimpler H., Brandner G., and Hess R.D. Flavonoids activate wild-type p53. Oncogene 13 (1996) 1605-1614
23. Liang Y.C., Tsai S.H., Tsai D.C., Lin-Shiau S.Y., and Lin J.K. Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett. 496 (2001) 12-18
24. Robak J., and Gryglewski R.J. Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol. 37 (1988) 837-841
25. Canada A.T., Giannella E., Nguyen T.D., and Mason R.P. The production of reactive oxygen species by dietary flavonoles. Free Radic. Biol. Med. 9 (1990) 441-449
26. Lopez-Lopez G., Moreno L., Cogolludo A., Galisteo M., Ibarra M., Duarte J., Lodi F., Tamargo J., and Perez-Vizcaino F. Nitric oxide scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. Mol. Pharmacol. 65 (2004) 851-859
27. Wada T., and Penninger J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23 (2004) 2838-2849
28. Seay U., Sedding D., Krick S., Hecker M., Seeger W., and Eickelberg O. Transforming growth factor-beta-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent. J. Pharmacol. Exp. Ther. 315 (2005) 1005-1012
29. Slevin M., Elasbali A.B., Miguel Turu M., Krupinski J., Badimon L., and Gaffney J. Identification of differential protein expression associated with development of unstable human carotid plaques. Am. J. Pathol. 168 (2006) 004-1021
30. Squadrito F., Minutoli L., Esposito M., Bitto A., Marini H., Seminara P., Crisafulli A., Passaniti M., Adamo E.B., Marini R., Guarini S., and Altavilla D. Lipid peroxidation triggers both c-Jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK) activation and neointimal hyperplasia induced by cessation of blood flow in the mouse carotid artery. Atherosclerosis 178 (2005) 295-302
31. Kim S., Izumi Y., Yano M., Hamaguchi A., Miura K., Yamanaka S., Miyazaki H., and Iwao H. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon injured artery. Circulation 97 (1998) 1731-1737
32. Izumi Y., Kim S., Namba M., Yasumoto H., Miyazaki H., Hoshiga M., Y K., Morishita R., Zhan Y., and Iwao H. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ. Res. 88 (2001) 1120-1126
33. Nakao A., Murase N., Ho C., Toyokawa H., Billiar T.R., and Kanno S. Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury. Circulation 112 (2005) 587-591